Molecular characterisation of the monocytic cell line THP-1 demonstrates a discrepancy with the documented HLA type

International Journal of Cancer

Volumn 132, Issue 1, 2013, Pages 246-247

  Battle, Richard ^a,b   Poole, Katherine ^b   Haywood Small, Sarah ^a   Clark, Brendan ^b   Woodroofe, M Nicola ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

HLA; PCR SSP; revised HLA type; THP 1

Indexed keywords

HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA A9 ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA B15 ANTIGEN; HLA B5 ANTIGEN; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DRW1 ANTIGEN; HLA DRW2 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; CANCER CELL CULTURE; CANCER GROWTH; CELL STRAIN THP 1; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; LETTER; LEUKEMIA CELL; MOLECULAR DYNAMICS; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL;

CELL LINE, TUMOR; HLA ANTIGENS; HUMANS; LEUKEMIA, MONOCYTIC, ACUTE; MONOCYTES;

EID: 84868194796     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27661     Document Type: Letter

References (13)

1. Tsuchiya S, Yamabe M, Yamaguchi Y, et al. Establishment and characterisation of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26: 171-6.
2. Hartung T, Balls M, Bardouille C, et al. Good cell culture practice, ECVAM good cell culture practice taskforce report 1. Altern Lab Anim 2002; 30: 407-14.
3. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355-67.
4. Downing J, Darke C,. A modified PCR-SSP method for identification of ABO blood group antigens. Eur J Immunogenet 2003; 30: 295-8.
5. Mendez R, Rodriguez T, Campo AD, et al. Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines. Cancer Immunol Immunotherapy 2008; 57: 719-29.
6. Garrido C, Paco L, Romero I, et al. MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells. Carcinogenesis 2012; 33: 687-93.
7. Gonzalez-Galarza FF, Christmas S, Middleton D, et al. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011; 39: D913-D919.
8. Maiers M, Gragent L, Klitz W,. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol 2008; 68: 779-88.
9. Bozon MV, Delgado JC, Selvakumar A, et al. Error rate for HLA-B antigen assignment by serology: implications for proficiency testing and utilization of DNA-based typing methods. Tissue Antigens 1997; 50: 387-97.
10. Bozon MV, Delgado JC, Turbay D, et al. Comparison of HLA-A antigen typing by serology with two polymerase chain reaction based DNA typing methods: implications for proficiency testing. Tissue Antigens 1996; 47: 512-8.
11. Woszczek G, Borowiec M, Gorska M, et al. Comparison of serological and molecular (PCR-SSP) techniques of HLA-DR typing in clinical laboratory routine. Ann Transplant 1997; 2: 39-42.
12. Vago L, Perna SK, Zanussi M, et al. Loss of mismatched HLA in leukemia after stem cell transplantation. N Engl J Med 2009; 361: 478-88.
13. Abrahamsen IW, Kjellevoll S, Greve-Isdahl M, et al. T cells raised against allogenic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells. Int J Cancer 2011; 30: 1821-32.